Transaction · 0001780664-26-000041
ADPTAdaptive Biotechnologies Corp
Rubinstein Julie
RUBINSTEIN JULIE, PRES, reported an open-market or private sale at Adaptive Biotechnologies Corp involving 6781.000000 shares for an estimated $173390.17. Reported holdings after the transaction were 382902.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Open-market sellSEC transaction code SPRES
- Trade date
- Oct 14, 2026
- Filing date
- Oct 16, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 389,683 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ADPT price since this filing
Daily closing prices, with the filing date and available return windowsADPT · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +3.2%1w ago +9.4%1d ago +5.2%
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001780664-26-000041 Common Stock
- Transaction date
- Oct 14, 2026 Filed Oct 16, 2026, 11:21 PM · 2d delay
- Shares
- 6,781 sh $25.57 per share
- Estimated value
- -$173k Computed from shares × price
- Holdings after
- 382,902 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
Filing-only score
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
Neutral filing signal
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
President and COO
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.
- F2
The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.70 to $25.70, inclusive. The reporting person undertakes…
- F3
The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.70 to $26.25, inclusive. The reporting person undertakes…
- F4
The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.19 to $25.90, inclusive. The reporting person undertakes…
- F5
The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.98 to $24.88, inclusive. The reporting person undertakes…
- F6
The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.29 to $25.55, inclusive. The reporting person undertakes…
- F7
The option is fully vested and exercisable.
Related transactions
Same SEC filing0 other transactions
Recent company activity
ADPT0 recent txs